Due to a high load of modelling projects, the rate of submission via the website has been reduced.
For a much higher submission rate, please use the Modelling API.

Multiple Assemblies exist for SMTL entry 5fbn
BTK kinase domain with inhibitor 1; X-RAY DIFFRACTION 1.80 Å

SMTL ID
5fbn.1
Ligands
4-[8-azanyl-3-[(3~{R})-1-(3-methyloxetan-3-yl)carbonylpiperidin-3-yl]imidazo[1,5-a]pyrazin-1-yl]-~{N}-[4-(trifluoromethyl)pyridin-2-yl]benzamide; 4-[8-azanyl-3-[(2~{S})-1-[4-(dimethylamino)butanoyl]pyrrolidin-2-yl]imidazo[1,5-a]pyrazin-1-yl]-~{N}-(1,3-thiazol-2-yl)benzamide; CHLORIDE ION
Polypeptides
Tyrosine-protein kinase BTK
Oligo-state
monomer
SMTL ID
5fbn.2
Ligands
CHLORIDE ION; 4-[8-azanyl-3-[(3~{R})-1-(3-methyloxetan-3-yl)carbonylpiperidin-3-yl]imidazo[1,5-a]pyrazin-1-yl]-~{N}-[4-(trifluoromethyl)pyridin-2-yl]benzamide; 4-[8-azanyl-3-[(2~{S})-1-[4-(dimethylamino)butanoyl]pyrrolidin-2-yl]imidazo[1,5-a]pyrazin-1-yl]-~{N}-(1,3-thiazol-2-yl)benzamide; 1,2-ETHANEDIOL
Polypeptides
Tyrosine-protein kinase BTK
Oligo-state
monomer